Patent · US Active

Antibody that binds to VEGF and IL-1beta and methods of use

US11130804B2 · kind B2 · utility

0Cited by

0References

28Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Roland Beckmann · Wien, AT
Joerg Benz · Rheinfelden (Baden), DE
Stefan Dengl · Munich, DE
Christian Gassner · Penzberg, DE
Guido Hartmann · Soest, DE
Peter Michael Huelsmann · Habach, DE
Sabine Imhof-Jung · Planegg, DE
Kristian Jensen · Munich, DE
Hubert Kettenberger · Munich, DE
Stefan Lorenz · Penzberg, DE
Joerg Moelleken · Penzberg, DE
Olaf Mundigl · Weilheim, DE

Key dates

Filing date	Dec 20, 2019
Grant date	Sep 28, 2021
Priority date	—
Expiry date	Dec 20, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-VEGF/anti-IL-1beta antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.